Jaguar Health, Inc. (NASDAQ:JAGX) | WebDisclosure

Basculer en Français

9480	Companies
185562	Keywords
117963	Articles
99396	Press releases

Home
Companies
Jaguar Health, Inc.

PRESS RELEASE

published on 05/15/2025 at 20:30, 6 months 21 days ago

Jaguar Health Reports First Quarter 2025 Financials
Jaguar Health, Inc. reports Q1 2025 financial results with revenue decrease, Mytesi prescription volume changes, and promising POC results for rare diseases. FDA meeting on Phase 3 trial for breast cancer subgroup

Financial Results Jaguar Health Q1 2025 Mytesi Prescription POC Results
BRIEF

published on 05/14/2025 at 15:05, 6 months 22 days ago

Jaguar Health organise un webcast pour les investisseurs concernant ses résultats financiers du premier trimestre 2025

Crofelemer Jaguar Health Médicaments Webcast Pour Les Investisseurs Résultats Financiers Du Premier Trimestre 2025
BRIEF

published on 05/14/2025 at 15:05, 6 months 22 days ago

Jaguar Health Schedules Investor Webcast for Q1 2025 Financials

Crofelemer Pharmaceuticals Investor Webcast Jaguar Health Q1 2025 Financials
PRESS RELEASE

published on 05/14/2025 at 15:00, 6 months 22 days ago

Jaguar Health to Hold Investor Webcast Thursday, May 15 at 4:15 PM Eastern Regarding Q1 2025 Financials & Corporate Updates
Jaguar Health, Inc. to file Q1 2025 Earnings Report on May 15, 2025 and conduct investor webcast. Focus on pharmaceuticals from rainforest plants for gastrointestinal distress

Pharmaceuticals Gastrointestinal Distress Earnings Report Investor Webcast Jaguar Health
BRIEF

published on 05/08/2025 at 15:35, 6 months 28 days ago

Jaguar Health met en avant la sensibilisation au cancer des animaux de compagnie grâce à ses initiatives de soins contre le cancer

Jaguar Health Chimiothérapie Cancer Des Animaux De Compagnie Canalevia ® -CA1 Sensibilisation Au Cancer
BRIEF

published on 05/08/2025 at 15:35, 6 months 28 days ago

Jaguar Health Highlights Pet Cancer Awareness with Its Cancer Care Initiatives

Jaguar Health Chemotherapy Canalevia®-CA1 Pet Cancer Cancer Awareness
PRESS RELEASE

published on 05/08/2025 at 15:30, 6 months 28 days ago

Jaguar Health Celebrates National Pet Cancer Awareness Month: With its Supportive Cancer Care Drugs, Jaguar is Dedicated to the Health and Wellbeing of People and Dogs
Jaguar Health, Inc. celebrates FDA conditional approval of Canalevia®-CA1 prescription drug for chemotherapy-induced diarrhea in dogs, highlighting National Pet Cancer Awareness Month and supportive cancer care initiatives

FDA Approval Jaguar Health Canalevia-CA1 Chemotherapy-induced Diarrhea National Pet Cancer Awareness Month
BRIEF

published on 05/07/2025 at 15:20, 6 months 29 days ago

Jaguar Health met en avant les développements clés de Crofelemer en 2025

Crofelemer Approbation De La FDA Maladies Rares Thérapie Contre Le Cancer Catalyseurs 2025
BRIEF

published on 05/07/2025 at 15:20, 6 months 29 days ago

Jaguar Health Highlights Key 2025 Developments for Crofelemer

Crofelemer FDA Approval Cancer Therapy Rare Diseases 2025 Catalysts
PRESS RELEASE

published on 05/07/2025 at 15:15, 6 months 29 days ago

Jaguar Health Provides Overview of 2025 Crofelemer-Related Catalysts
Jaguar Health's crofelemer, the only oral drug approved under FDA's Botanical Guidance, shows promising results in rare disease and cancer therapy-related diarrhea programs. Expected Q2-Q4 2025 catalysts discussed

FDA Crofelemer Jaguar Health Catalysts Oral Drug

Accesswire

Published on 12/05/2025 at 23:30, 20 minutes ago

55 North Mining Inc. Announces Completion of Third and Final Tranche of Private Placement for a Total of $4,202,000
Published on 12/05/2025 at 22:50, 1 hour ago

Banyan Gold Grants Incentive Stock Options
Published on 12/05/2025 at 21:45, 2 hours 5 minutes ago

When the Architecture Becomes Visible: The SMX Revaluation Explained
Published on 12/05/2025 at 21:30, 2 hours 20 minutes ago

The Identity Layer Beneath Everything: Why Markets Are Revaluing SMX All at Once
Published on 12/05/2025 at 21:20, 2 hours 30 minutes ago

Medicus Pharma Ltd. Enters Into $5.1 Million Warrant Inducement

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 22:15, 1 hour 34 minutes ago

CPI PROPERTY GROUP - Changes in Shareholding and Board of Directors
Published on 12/05/2025 at 22:12, 1 hour 37 minutes ago

EQS-Adhoc: CPI PROPERTY GROUP - Change to Distribution Policy
Published on 12/05/2025 at 18:58, 4 hours 51 minutes ago

EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:26, 5 hours 23 minutes ago

POS-Transaction in Own Shares
Published on 12/05/2025 at 18:15, 5 hours 34 minutes ago

Completion of merger to form Helvetia Baloise Holding Ltd

Les Echos

Published on 12/05/2025 at 23:00, 50 minutes ago

ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 50 minutes ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 50 minutes ago

ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 23:00, 50 minutes ago

ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 17:18, 6 hours 32 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible

View all LES ECHOS COMFI WIRE